JP Morgan Chase’s ResMed RMD Stock Holding History

JP Morgan Chase’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Hold	9,200	–	–	﹤0.01%	4253
2026 Q1	$2.02M	Hold	9,200	–	–	﹤0.01%	4089
2025 Q4	$2.22M	Hold	9,200	–	–	﹤0.01%	3998
2025 Q3	$2.52M	Hold	9,200	–	–	﹤0.01%	3904
2025 Q2	$2.37M	Buy	+9,200	New	+$2.19M	﹤0.01%	3775
2025 Q1	–	Sell	-2,500	Closed	-$572K	–	7663
2024 Q4	$572K	Buy	+2,500	New	+$602K	﹤0.01%	4973
2024 Q3	–	Sell	-1,200	Closed	-$230K	–	7635
2024 Q2	$230K	Hold	1,200	–	–	﹤0.01%	5096
2024 Q1	$238K	Buy	+1,200	New	+$220K	﹤0.01%	5257
2014 Q4	–	Sell	-90,000	Closed	-$4.43M	–	4335
2014 Q3	$4.43M	Buy	+90,000	New	+$4.58M	﹤0.01%	2441

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase's RMD Position: Q2 2026 in Review

JP Morgan Chase increased its ResMed (RMD) stake by 18% in Q2 2026, buying an estimated $26.6M and bringing the position to 833,536 shares worth $165M. The position accounts for 0.01% of the portfolio, ranked #821.

JP Morgan Chase first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $306M in Q4 2020. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

JP Morgan Chase held 833,536 shares of ResMed worth $165M as of Q2 2026.
JP Morgan Chase bought 128,389 ResMed shares in Q2 2026, an estimated $26.6M.
ResMed made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #821 holding.
JP Morgan Chase first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
JP Morgan Chase's ResMed position peaked at $306M in Q4 2020.
888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.